Crotonylation of MCM6 enhances chemotherapeutics sensitivity of breast cancer via inducing DNA replication stress

Abstract

Breast cancer is associated with high morbidity and mortality, which are closely influenced by protein post-translational modifications (PTMs). Lysine crotonylation (Kcr) serves as a newly identified PTM type that plays a role in various biological processes; however, its involvement in breast cancer progression remains unclear. Minichromosome maintenance 6 (MCM6) is a critical component of DNA replication and has been previous confirmed to exhibit a significant role in tumorigenesis. Despite this, a comprehensive analysis of MCM6, particularly regarding its modifications in breast cancer is lacking. In this study, we found MCM6 is upregulated in breast invasive carcinoma (BRCA) and is associated with poorer overall survival by regulating the DNA damage repair mechanisms. Furthermore, MCM6-knockdown resulted in decreased cell proliferation and inhibited the DNA replication, leading to DNA replication stress and sustained DNA damage, thereby enhancing the chemotherapeutic sensitivity of breast cancer. Additionally, SIRT7-mediated crotonylation of MCM6 at K599 (MCM6-K599cr) was significantly upregulated in response to DNA replication stress, primarily due to the disassemebly of the MCM2-7 complex and regulated by RNF8-mediated ubiquitination. Concurrently, kaempferol, which acts as a regulator of SIRT7, was found to enhance the Kcr level of MCM6, reducing tumour weight, particular when combined with paclitaxel, highlighting its potential chemotherapeutic target for BRCA therapy.

References

[1] SiegelRL, MillerKD, WagleNS, Jemal A. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17-48.

[2] TrennerA, Sartori AA. Harnessing DNA double-strand break repair for cancer treatment. Front Oncol. 2019;9:1388.

[3] HuangRX, ZhouPK. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer. Signal Transduct Target Ther. 2020;5(1):60.

[4] CarusilloA, Mussolino C. DNA damage: from threat to treatment. Cells. 2020;9(7):1665.

[5] OlivieriM, ChoT, Álvarez-QuilónA, et al. A genetic map of the response to DNA damage in human cells. Cell. 2020;182(2):481-496.

[6] AlghoulE, Basbous J, ConstantinouA. Compartmentalization of the DNA damage response: mechanisms and functions. DNA Repair. 2023;128:103524.

[7] GroellyFJ, FawkesM, DaggRA, Blackford AN, TarsounasM. Targeting DNA damage response pathways in cancer. Nat Rev Cancer. 2023;23(2):78-94.

[8] JurkovicovaD, Neophytou CM, Gašparović A, GonçalvesAC. DNA damage response in cancer therapy and resistance: challenges and opportunities. Int J Mol Sci. 2022;23(23):14672.

[9] da CostaA, Chowdhury D, ShapiroGI, D’AndreaAD, Konstantinopoulos PA. Targeting replication stress in cancer therapy. Nat Rev Drug Discov. 2023;22(1):38-58.

[10] UbhiT, BrownGW. Exploiting DNA replication stress for cancer treatment. Cancer Res. 2019;79(8):1730-1739.

[11] BriuLM, MaricC, CadoretJC. Replication stress, genomic instability, and replication timing: a complex relationship. Int J Mol Sci. 2021;22(9):4764.

[12] LewisJS, GrossMH, SousaJ, et al. Mechanism of replication origin melting nucleated by CMG helicase assembly. Nature. 2022;606(7916):1007-1014.

[13] YuJ, WangR, WuJ, DangZ, ZhangQ, Li B. Knockdown of minichromosome maintenance proteins inhibits foci forming of mediator of DNA-damage checkpoint 1 in response to DNA damage in human esophageal squamous cell carcinoma TE-1 cells. Biochemistry. 2016;81(10):1221-1228.

[14] LiL, FengY, LuoR. Minichromosome maintenance complex is required for checkpoint kinase 2 chromatin loading and its phosphorylation to DNA damage response in SCC-4 cells. Protein Pept Lett. 2017;24(3):223-228.

[15] PougetC, Hergalant S, LardenoisE, et al. Ki-67 and MCM6 labeling indices are correlated with overall survival in anaplastic oligodendroglioma, IDH1-mutant and 1p/19q-codeleted: a multicenter study from the French POLA network. Brain Pathol. 2020;30(3):465-478.

[16] SchraderC, Janssen D, KlapperW, et al. Minichromosome maintenance protein 6, a proliferation marker superior to Ki-67 and independent predictor of survival in patients with mantle cell lymphoma. Br J Cancer. 2005;93(8):939-945.

[17] LuoY, YangY, YangC, et al. UBE3A and MCM6 synergistically regulate the proliferation and migration of lung adenocarcinoma cells. FEBS Open Bio. 2023;13(9):1756-1771.

[18] HsuEC, ShenM, AslanM, et al. MCM2-7 complex is a novel druggable target for neuroendocrine prostate cancer. Sci Rep. 2021;11(1):13305.

[19] FengX, SongD, LiuX, et al. RNF125-mediated ubiquitination of MCM6 regulates the proliferation of human liver hepatocellular carcinoma cells. Oncol Lett. 2024;27(3):105.

[20] ZhangX, BianS, NiY, et al. Minichromosome maintenance protein family member 6 mediates hepatocellular carcinoma progression by recruiting UBE3A to induce P53 ubiquitination. Int J Biol Macromol. 2023;248:125854.

[21] WanJ, LiuH, ChuJ, ZhangH. Functions and mechanisms of lysine crotonylation. J Cell Mol Med. 2019;23(11):7163-7169.

[22] JiangG, LiC, LuM, LuK, LiH. Protein lysine crotonylation: past, present, perspective. Cell Death Dis. 2021;12(7):703.

[23] WangS, MuG, QiuB, et al. The function and related diseases of protein crotonylation. Int J Biol Sci. 2021;17(13):3441-3455.

[24] SongH, ShenR, LiuX, et al. Histone post-translational modification and the DNA damage response. Genes Dis. 2023;10(4):1429-1444.

[25] JiP, ZhangG, GuoY, et al. Protein crotonylation: an emerging regulator in DNA damage response. Life Sci. 2023;331:122059.

[26] Abu-ZhayiaER, Machour FE, AyoubN. HDAC-dependent decrease in histone crotonylation during DNA damage. J Mol Cell Biol. 2019;11(9):804-806.

[27] ZhangY, ChenY, ZhangZ, et al. Acox2 is a regulator of lysine crotonylation that mediates hepatic metabolic homeostasis in mice. Cell Death Dis. 2022;13(3):279.

[28] ZhangD, TangJ, XuY, et al. Global crotonylome reveals hypoxia-mediated lamin a crotonylation regulated by HDAC6 in liver cancer. Cell Death Dis. 2022;13(8):717.

[29] ZhengY, ZhuL, QinZY, et al. Modulation of cellular metabolism by protein crotonylation regulates pancreatic cancer progression. Cell Rep. 2023;42(7):112666.

[30] RaguS, Matos-Rodrigues G, LopezBS. Replication stress, DNA damage, inflammatory cytokines and innate immune response. Genes. 2020;11(4):409.

[31] GuoZ, TianY, GuoY, et al. RAD6B plays a critical role in neuronal DNA damage response to resist neurodegeneration. Front Cell Neurosci. 2019;13:392.

[32] GuoY, ShenR, YangK, et al. RNF8 enhances the sensitivity of PD-L1 inhibitor against melanoma through ubiquitination of galectin-3 in stroma. Cell Death Discov. 2023;9(1):205.

[33] LiuC, WangD, WuJ, KellerJ, MaT, YuX. RNF168 forms a functional complex with RAD6 during the DNA damage response. J Cell Sci. 2013;126(Pt 9):2042-2051.

[34] HaoS, WangY, ZhaoY, et al. Dynamic switching of crotonylation to ubiquitination of H2A at lysine 119 attenuates transcription-replication conflicts caused by replication stress. Nucleic Acids Res. 2022;50(17):9873-9892.

[35] ConradE, Polonio-Vallon T, MeisterM, et al. HIPK2 restricts SIRT1 activity upon severe DNA damage by a phosphorylation-controlled mechanism. Cell Death Differ. 2016;23(1):110-122.

[36] ZhangP, Brinton LT, WilliamsK, et al. Targeting DNA damage repair functions of two histone deacetylases, HDAC8 and SIRT6, sensitizes acute myeloid leukemia to NAMPT inhibition. Clin Cancer Res. 2021;27(8):2352-2366.

[37] NagaiK, Matsushita T, MatsuzakiT, et al. Depletion of SIRT6 causes cellular senescence, DNA damage, and telomere dysfunction in human chondrocytes. Osteoarthr Cartil. 2015;23(8):1412-1420.

[38] TangM, LiZ, ZhangC, et al. SIRT7-mediated ATM deacetylation is essential for its deactivation and DNA damage repair. Sci Adv. 2019;5(3):eaav1118.

[39] TangM, TangH, TuB, ZhuWG. SIRT7: a sentinel of genome stability. Open Biol. 2021;11(6):210047.

[40] VazquezBN, Thackray JK, SimonetNG, et al. SIRT7 promotes genome integrity and modulates non-homologous end joining DNA repair. EMBO J. 2016;35(14):1488-1503.

[41] YuJ, YuanS, SongJ, Yu S. USP39 interacts with SIRT7 to promote cervical squamous cell carcinoma by modulating autophagy and oxidative stress via FOXM1. J Transl Med. 2023;21(1):807.

[42] KopustinskieneDM, Jakstas V, SavickasA, BernatonieneJ. Flavonoids as anticancer agents. Nutrients. 2020;12:2.

[43] GeorgeVC, Dellaire G, RupasingheHPV. Plant flavonoids in cancer chemoprevention: role in genome stability. J Nutr Biochem. 2017;45:1-14.

[44] KangJW, KimJH, SongK, Kim SH, YoonJH, KimKS. Kaempferol and quercetin, components of Ginkgo biloba extract (EGb 761), induce caspase-3-dependent apoptosis in oral cavity cancer cells. Phytother Res. 2010;24(Suppl 1):S77-S82.

[45] ChenQY, LiuLC, WangJB, et al. CDK5RAP3 inhibits the translocation of MCM6 to influence the prognosis in gastric cancer. J Cancer. 2019;10(19):4488-4498.

[46] WangY, ChenH, LiuW, et al. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target. Theranostics. 2022;12(15):6509-6526.

[47] ZengT, GuanY, LiYK, et al. The DNA replication regulator MCM6: an emerging cancer biomarker and target. Clin Chim Acta. 2021;517:92-98.

[48] ZhangL, ChenW, LiuS, ChenC. Targeting breast cancer stem cells. Int J Biol Sci. 2023;19(2):552-570.

[49] AzzoniV, Wicinski J, MacarioM, et al. BMI1 nuclear location is critical for RAD51-dependent response to replication stress and drives chemoresistance in breast cancer stem cells. Cell Death Dis. 2022;13(2):96.

[50] VenugopalK, FengY, NowialisP, et al. DNMT3A harboring leukemia-associated mutations directs sensitivity to DNA damage at replication forks. Clin Cancer Res. 2022;28(4):756-769.

[51] XuW, WanJ, ZhanJ, et al. Global profiling of crotonylation on non-histone proteins. Cell Res. 2017;27(7):946-949.

[52] ChenW, TangD, XuY, et al. Comprehensive analysis of lysine crotonylation in proteome of maintenance hemodialysis patients. Medicine. 2018;97(37):e12035.

[53] LokGT, SySMH, DongSS, Ching YP, TsaoSW. Differential regulation of RNF8-mediated Lys48-and Lys63-based poly-ubiquitylation. Nucleic Acids Res. 2012;40(1):196-205.

[54] PeriferakisA, Periferakis K, BadarauIA, et al. Kaempferol: antimicrobial properties, sources, clinical, and traditional applications. Int J Mol Sci. 2022;23(23):15054.

[55] CriscitielloC, CortiC. Breast cancer genetics: diagnostics and treatment. Genes. 2022;13(9):1593.

[56] LiT, FuJ, ZengZ, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509-w514.

[57] TangZ, KangB, LiC, ChenT, ZhangZ. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556-w560.

[58] di MiccoP, Antolin AA, MitsopoulosC, et al. canSAR: update to the cancer translational research and drug discovery knowledgebase. Nucleic Acids Res. 2023;51(D1):D1212-d1219.

[59] PiñeroJ, Ramírez-Anguita JM, Saüch-PitarchJ, et al. The DisGeNET knowledge platform for disease genomics:2019 update. Nucleic Acids Res. 2020;48(D1):D845-d855.

[60] YangS, KimCY, HwangS, et al. COEXPEDIA: exploring biomedical hypotheses via co-expressions associated with medical subject headings (MeSH). Nucleic Acids Res. 2017;45(D1):D389-d396.

[61] ZhouY, ZhouB, PacheL, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.

[62] ChenM, ZhangW, GouY, et al. GPS 6.0: an updated server for prediction of kinase-specific phosphorylation sites in proteins. Nucleic Acids Res. 2023;51(W1):W243-w250.

[63] GillotinS. Isolation of chromatin-bound proteins from subcellular fractions for biochemical analysis. Bio Protoc. 2018;8(19):e3035.

[64] LuY, GuX, WanQ, FengH, LiuY. Co-immunofluorescence of MRPL12 and Nrf2 in HK2 cells. Bio Protoc. 2021;11(20):e4191.

[65] HalliwellJA, Gravells P, BryantHE. DNA fiber assay for the analysis of DNA replication progression in human pluripotent stem cells. Curr Protoc Stem Cell Biol. 2020;54(1):e115.

[66] ClementiE, Garajova Z, MarkkanenE. Measurement of DNA damage using the neutral comet assay in cultured cells. Bio Protoc. 2021;11(22):e4226.

RIGHTS & PERMISSIONS

2024 The Author(s). Cell Proliferation published by Beijing Institute for Stem Cell and Regenerative Medicine and John Wiley & Sons Ltd.